Mostrar el registro sencillo del ítem

Endocrine therapy synergizes with smac mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer

dc.contributor.authorHermida Prado, Francisco José 
dc.contributor.authorXie, Y.
dc.contributor.authorSherman, S.
dc.contributor.authorNagy, Z.
dc.date.accessioned2024-02-26T07:38:46Z
dc.date.available2024-02-26T07:38:46Z
dc.date.issued2023
dc.identifier.citationCancer Research, 83(19), p. 3284-3304 (2023); doi:10.1158/0008-5472.CAN-23-1711
dc.identifier.issn0008-5472
dc.identifier.urihttps://hdl.handle.net/10651/71603
dc.description.statementofresponsibilityHermida-Prado F., Xie Y., Sherman S., Nagy Z., Russo D., Akhshi T., Chu Z., Feit A., Campisi M., Chen M., Nardone A., Guarducci C., Lim K., Font-Tello A., Lee I., García-Pedrero J., Cañadas I., Agudo J., Huang Y., Sella T., Jin Q., Tayob N., Mittendorf E.A., Tolaney S.M., Qiu X., Long H., Symmans W.F., Jia-Ren L., Santagata S., Bedrosian I., Yardley D.A., Mayer I.A., Richardson E.T., Oliveira G., Wu C.J., Schuster E.F., Dowsett M., Welm A.L., Barbie D., Metzger O., Jeselsohn R.
dc.format.extentp. 3284-3304
dc.language.isoeng
dc.relation.ispartofCancer Research
dc.rights© 2023, American Association for Cancer Research.
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85174080137&doi=10.1158%2f0008-5472.CAN-23-1711&partnerID=40&md5=947b21225d2a765843d35dc6cb88c53d
dc.titleEndocrine therapy synergizes with smac mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer
dc.typejournal article
dc.identifier.doi10.1158/0008-5472.CAN-23-1711
dc.relation.publisherversionhttp://dx.doi.org/10.1158/0008-5472.CAN-23-1711
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2023, American Association for Cancer Research.
Este ítem está sujeto a una licencia Creative Commons